Last reviewed · How we verify

NCT03745560

Intraoperative EABR for Decision Making

Recruiting now Last updated 25 November 2024
What this trial tests

trial in Vestibular Schwannoma in 15 participants. Currently enrolling.

Timeline
23 May 2017
Primary endpoint
23 May 2026
23 May 2026

Quick facts

Lead sponsorChristoph Arnoldner
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment15
Start date23 May 2017
Primary completion23 May 2026
Estimated completion23 May 2026
Sites1 location across Austria

Conditions studied

Sponsor

Christoph Arnoldner

Who can join

Adults 18 to 99, any sex, with Vestibular Schwannoma or Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study patients undergoing simultaneous translabyrinthine vestibular schwannoma resection and cochlear implantation are included. The goal of the study is to correlate the eABR results with postoperative hearing results.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A novel scoring system based on small vestibular schwannomas to determine consideration for cochlear implantation.
    Arnoldner C, Schwarz-Nemec U, Auinger AB, Yildiz E, et al · · 2021 · cited 11× · PMID 34080297 · DOI 10.1111/coa.13819

Verify or expand the search:

Other recruiting trials for Vestibular Schwannoma

Currently open trials in the same condition.

Other Christoph Arnoldner trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03745560.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing